Twenty-two years' experience with childhood-onset SLE in a developing country: Are outcomes similar to developed countries?

Archives of Disease in Childhood

Volumn 96, Issue 1, 2011, Pages 44-49

  Vachvanichsanong, Prayong ^a   Dissaneewate, Pornsak ^a   McNeil, Edward ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADOLESCENT; AGE; ARTICLE; CHILD; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THAILAND;

ADOLESCENT; AGE DISTRIBUTION; CHILD; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; EPIDEMIOLOGIC METHODS; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; PREDNISOLONE; PROGNOSIS; SEX DISTRIBUTION; THAILAND; TREATMENT OUTCOME;

EID: 78650850970     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.183699     Document Type: Article

References (31)

1. Perfumo F, Martini A. Lupus nephritis in children. Lupus 2005;14:83-8.
2. Klein-Gitelman M, Reiff A, Silverman ED. Systemic lupus erythematosus in childhood. Rheum Dis Clin North Am 2002;28:561-77, vi-vii.
3. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999;10:413-24.
4. Yang LY, Chen WP, Lin CY. Lupus nephritis in children - a review of 167 patients. Pediatrics 1994;94:335-40.
5. Vachvanichsanong P, Dissaneewate P. Childhood systemic lupus erythematosus in songklanagarind hospital: a potential unique subgroup. Clin Rheumatol 1993;12:346-9. (Pubitemid 23306869)
6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
7. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241-50.
8. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. 2006. http://www.R-project.org (accessed 20 August 2008).
9. Bakr A. Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt. Pediatr Nephrol 2005;20:1081-6.
10. Bogdanovic R, Nikolic V, Pasic S, et al. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 2004;19:36-44. (Pubitemid 38088248)
11. Hiraki LT, Benseler SM, Tyrrell PN, et al. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 2008;152:550-6.
12. Wang LC, Yang YH, Lu MY, et al. Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J Microbiol Immunol Infect 2003;36:203-8.
13. Hagelberg S, Lee Y, Bargman J, et al. Longterm followup of childhood lupus nephritis. J Rheumatol 2002;29:2635-42.
14. Lee BS, Cho HY, Kim EJ, et al. Clinical outcomes of childhood lupus nephritis: a single center's experience. Pediatr Nephrol 2007;22:222-31.
15. Wong SN, Tse KC, Lee TL, et al. Lupus nephritis in Chinese children - a territory-wide cohort study in Hong Kong. Pediatr Nephrol 2006;21:1104-12.
16. Wang LC, Yang YH, Lu MY, et al. Retrospective analysis of the renal outcome of pediatric lupus nephritis. Clin Rheumatol 2004;23:318-23.
17. Emre S, Bilge I, Sirin A, et al. Lupus nephritis in children: prognostic significance of clinicopathological findings. Nephron 2001;87:118-26. (Pubitemid 32215822)
18. Iseki K, Miyasato F, Oura T, et al. An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 1994;23:547-54.
19. Anonymous. Lupus nephritis: prognostic factors and probability of maintaining life supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 1992;19:473-9.
20. Laoprasopwattana K, Dissaneewate P, Vachvanichsanong P. Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide. Pediatr Nephrol 2009;24:1337-43.
21. Opastirakul S, Chartapisak W. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy. Pediatr Nephrol 2005;20:1750-5.
22. Hiraki LT, Hamilton J, Silverman ED. Measuring permanent damage in pediatric systemic lupus erythematosus. Lupus 2007;16:657-62.
23. Nossent HC, Koldingsnes W. Long-term efficacy of azathioprine treatment for proliferative lupus nephritis. Rheumatology (Oxford) 2000;39:969-74.
24. Neumann K, Wallace DJ, Azen C, et al. Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 1995;25:47-55.
25. Lehman TJ, Onel K. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 2000;136:243-7.
26. Valeri A, Radhakrishnan J, Estes D, et al. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study. Clin Nephrol 1994;42:71-8.
27. Austin HA, 3rd, Klippel JH, Balow JE, et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986;314:614-19.
28. Al Salloum AA. Cyclophosphamide therapy for lupus nephritis: poor renal survival in Arab children. Pediatr Nephrol 2003;18:357-61.
29. Mok CC, Wong RW, Lau CS. Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome. Am J Kidney Dis 1999;34:315-23.
30. MacGowan JR, Ellis S, Griffiths M, et al. Retrospective analysis of outcome in a cohort of patients with lupus nephritis treated between 1977 and 1999. Rheumatology (Oxford) 2002;41:981-7.
31. Bono L, Cameron JS, Hicks JA. The very long-term prognosis and complications of lupus nephritis and its treatment. QJM 1999;92:211-18.